Wall Street analysts expect LHC Group, Inc. (NASDAQ:LHCG) to announce $521.88 million in sales for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for LHC Group’s earnings, with the highest sales estimate coming in at $528.60 million and the lowest estimate coming in at $511.07 million. LHC Group posted sales of $502.02 million during the same quarter last year, which suggests a positive year-over-year growth rate of 4%. The business is expected to issue its next earnings results on Wednesday, August 7th.
On average, analysts expect that LHC Group will report full year sales of $2.11 billion for the current year, with estimates ranging from $2.10 billion to $2.12 billion. For the next fiscal year, analysts anticipate that the firm will report sales of $2.23 billion, with estimates ranging from $2.20 billion to $2.27 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover LHC Group.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.08. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. The firm had revenue of $502.59 million during the quarter, compared to analyst estimates of $511.16 million.
In related news, Director Ronald T. Nixon sold 12,000 shares of the stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $117.20, for a total value of $1,406,400.00. Following the completion of the sale, the director now directly owns 29,100 shares of the company’s stock, valued at approximately $3,410,520. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Keith G. Myers sold 75,000 shares of the stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $108.53, for a total transaction of $8,139,750.00. The disclosure for this sale can be found here. Insiders sold a total of 130,324 shares of company stock valued at $14,222,700 over the last three months. 5.20% of the stock is currently owned by insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Citigroup Inc. boosted its stake in LHC Group by 265.2% in the 4th quarter. Citigroup Inc. now owns 4,386 shares of the health services provider’s stock worth $412,000 after purchasing an additional 3,185 shares during the period. Everence Capital Management Inc. boosted its stake in LHC Group by 43.6% in the 1st quarter. Everence Capital Management Inc. now owns 4,050 shares of the health services provider’s stock worth $449,000 after purchasing an additional 1,230 shares during the period. Eqis Capital Management Inc. boosted its stake in LHC Group by 6.2% in the 4th quarter. Eqis Capital Management Inc. now owns 4,837 shares of the health services provider’s stock worth $454,000 after purchasing an additional 281 shares during the period. Campbell Newman Asset Management Inc. boosted its stake in LHC Group by 2.4% in the 1st quarter. Campbell Newman Asset Management Inc. now owns 6,350 shares of the health services provider’s stock worth $704,000 after purchasing an additional 151 shares during the period. Finally, Financial Gravity Companies Inc. bought a new position in LHC Group in the 4th quarter worth approximately $49,000. 93.88% of the stock is owned by institutional investors.
NASDAQ LHCG opened at $114.49 on Monday. LHC Group has a 52 week low of $74.00 and a 52 week high of $122.20. The stock has a market cap of $3.61 billion, a PE ratio of 32.25, a price-to-earnings-growth ratio of 2.02 and a beta of 0.87. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.21.
LHC Group Company Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Recommended Story: What does a market perform rating mean?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.